Skip to main content
Clinical Trials/JPRN-C000000358
JPRN-C000000358
Unknown
Phase 2

A Phase II study of induction chemotherapy S-1 and CDDP in patients with FDG-PET positive N2 disease of non-small cell lung cancer. - Induction therapy for N2 positive NSCLC

Fukushima Medical University0 sites25 target enrollmentApril 1, 2006

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Fukushima Medical University
Enrollment
25
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2006
End Date
December 1, 2010
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. active interstitial pneumonia 2\. active infectious disease 3\. active other cancer 4\. severe drug allergy 5\. severe complications

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A Phase I study of induction chemotherapy with S-1 and Cisplatin plus intraperitoneal administration of Docetaxel for gastric cancer with peritoneal disseminatiogastric cancer
JPRN-UMIN000002524Department of Surgery Graduate School of Medicine, Kyoto University15
Active, not recruiting
Not Applicable
Phase I/II study on induction chemotherapy followed by chemoradiation with or without lapatinib, a dual EGFR/ErbB2 kinase inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma
EUCTR2006-002667-33-BEEuropean Organisation for Research and Treatment of Cancer
Completed
Phase 2
The phase II study of induction chemotherapy with cetuximab/S-1/low dose cisplatin for oral squamous cell carcinoma patientsoral squamous cell carcinoma
JPRN-UMIN000014632The workshop of chemotherapy for oral cancer55
Recruiting
Not Applicable
A phase 2 study of induction chemotherapy followed by chemoradiotherapy for patients with borderline resectable pancreatic cancerPancreatic cancer
JPRN-UMIN000034410Keio University School of Medicine40
Active, not recruiting
Phase 1
Phase I/II study of Induction Chemotherapy with weekly RAD001, Carboplatine and Paclitaxel in Unresectable or Inoperable Locally Advanced Head and NeckSquamous Cell Carcinoma (HNSCC) - CAPRAnresectable or Inoperable locally advanced head and neck squamous cellcarcinoma without any prior chemotherapy or radiotherapyMedDRA version: 9.1Level: PTClassification code 10041823Term: Squamous cell carcinoma
EUCTR2008-005702-39-FRGERCOR50